-+ 0.00%
-+ 0.00%
-+ 0.00%
Some Investors May Be Willing To Look Past Pfizer's (NYSE:PFE) Soft Earnings
Share
Listen to the news

The most recent earnings report from Pfizer Inc. (NYSE:PFE) was disappointing for shareholders. Despite the soft profit numbers, our analysis has optimistic about the overall quality of the income statement.

earnings-and-revenue-history
NYSE:PFE Earnings and Revenue History November 10th 2026

How Do Unusual Items Influence Profit?

For anyone who wants to understand Pfizer's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$16b due to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. Pfizer took a rather significant hit from unusual items in the year to September 2026. All else being equal, this would likely have the effect of making the statutory profit look worse than its underlying earnings power.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Pfizer's Profit Performance

As we mentioned previously, the Pfizer's profit was hampered by unusual items in the last year. Because of this, we think Pfizer's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! Unfortunately, though, its earnings per share actually fell back over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Pfizer, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 4 warning signs for Pfizer you should know about.

This note has only looked at a single factor that sheds light on the nature of Pfizer's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending